Walgreens Boots Alliance Stock

$11.52

0.35% yesterday

Nasdaq, Jul 11, 10:12 pm CET

ISIN

US9314271084

Symbol

WBA

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P 500

Sector

Consumer goods

Industry

Drugstore chains

Overview Dividends Analysts Charts News Strategies

Walgreens Boots Alliance Stock price

$11.52

-28.06 70.89% 5Y

Nasdaq, Closing price Fri, Jul 11 2025

-0.04 0.35%

ISIN

US9314271084

Symbol

WBA

Reports

Quarter | Annual

Index

NASDAQ Composite, S&P 500

Sector

Consumer goods

Industry

Drugstore chains

Key metrics

Basic

Market capitalization

$10.0b

Enterprise Value

$17.8b

Net debt

$7.9b

Cash

$1.1b

Shares outstanding

864.5m

Valuation (TTM | estimate)

P/E

negative | 6.6

P/S

0.1 | 0.1

EV/Sales

0.1 | 0.1

EV/FCF

31.2

P/B

1.4

Dividends

DPS

$1.23

Yield 1Y | 5Y

10.7% | 4.5%

Growth 1Y | 5Y

-35.9% | -7.1%

Payout 1Y | 3Y

-12.3% | -59.1%

Increased

0 Years

Financials (TTM | estimate)

Revenue

$151.9b | $155.5b

EBITDA

$6.1b | $3.8b

EBIT

$3.7b | $2.0b

Net Income

$-5.8b | $1.5b

Free Cash Flow

$572.0m

Growth (TTM | estimate)

Revenue

5.1% | 5.3%

EBITDA

39.3% | -24.5%

EBIT

86.0% | -20.8%

Net Income

4.3% | 117.5%

Free Cash Flow

132.4%

Financial Health

Equity Ratio

12.9%

Return on Equity

-82.7%

ROCE

8.4%

ROIC

8.9%

Debt/Equity

1.3

EPS

$-6.7

FCF per Share

$0.7

Short interest

3.1%

Employees

253k

Rev per Employee

$580.0k

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Get Started for Free Today

Walgreens Boots Alliance Stock Analysis

Unlock Scores for Free

??

18 Analysts have issued a Walgreens Boots Alliance forecast:

4x Buy

22%

14x Hold

78%

More details on Analyst Estimates Including Price Targets

18 Analysts have issued a Walgreens Boots Alliance forecast:

Buy

22%

Hold

78%

Analyst Estimates with Stock Price Targets

Financial data from Walgreens Boots Alliance

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Feb '25		+/- %
Revenue	151,945 151,945	5% 5% 100%
- Direct Costs	125,520 125,520	7% 7% 83%
Gross Profit	26,425 26,425	2% 2% 17%
- Selling and Administrative Expenses	22,761 22,761	8% 8% 15%
- Research and Development Expense	- -	- -
EBITDA	6,132 6,132	39% 39% 4%
- Depreciation and Amortization	2,465 2,465	1% 1% 2%
EBIT (Operating Income) EBIT	3,667 3,667	86% 86% 2%
Net Profit	-5,779 -5,779	4% 4% -4%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Walgreens Boots Alliance Stock News

Positive

Seeking Alpha

●

about 19 hours ago

Dogs Of The S&P 500: 14 Ideal 'Safer' July Dividend Buys

High-yield S&P 500 stocks can be risky, but 14 "safer" S&P 500 dividend dogs have strong free cash flow to support payouts and are attractive buys. Analyst forecasts suggest top ten S&P 500 dividend dogs could deliver 27% to 53% net gains by July 2026, with lower-than-market volatility. A market correction could make more high-yield stocks fairly priced; currently, only a select few meet the 'd...

Positive

Forbes

●

one day ago

Walgreens Shareholders Approve $10 Billion Private Equity Buyout

Walgreens Boots Alliance shareholders Friday approved private equity firm Sycamore Partners' $10 billion buyout offer for the iconic drugstore chain.

Neutral

Business Wire

●

one day ago

Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “Company” or “WBA”) today announced that at the Company's Special Meeting of Shareholders (the “Special Meeting”), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. (“Sycamore”). According to the preliminary results, appro...

More Walgreens Boots Alliance News

Company Profile

Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.

Head office	United States
CEO	Timothy Wentworth
Employees	252,500
Founded	1909
Website	www.walgreensbootsalliance.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now